These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25275846)

  • 21. Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.
    Kopalli SR; Kang TB; Koppula S
    Expert Opin Ther Pat; 2016 Nov; 26(11):1239-1256. PubMed ID: 27568917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
    Nishimoto N
    Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.
    Dufton N; Perretti M
    Pharmacol Ther; 2010 Aug; 127(2):175-88. PubMed ID: 20546777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway.
    Lee KC; Chang HH; Chung YH; Lee TY
    J Ethnopharmacol; 2011 Jun; 135(3):678-84. PubMed ID: 21497192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Professional and part-time chemokine decoys in the resolution of inflammation.
    Hansell C; Nibbs R
    Sci STKE; 2007 May; 2007(384):pe18. PubMed ID: 17473307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages.
    McColl A; Bournazos S; Franz S; Perretti M; Morgan BP; Haslett C; Dransfield I
    J Immunol; 2009 Aug; 183(3):2167-75. PubMed ID: 19597001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen sulfide as a therapeutic target for inflammation.
    Rivers JR; Badiei A; Bhatia M
    Expert Opin Ther Targets; 2012 May; 16(5):439-49. PubMed ID: 22448627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases.
    Shang P; Zhang Y; Ma D; Hao Y; Wang X; Xin M; Zhang Y; Zhu M; Feng J
    Expert Opin Ther Targets; 2019 Nov; 23(11):967-986. PubMed ID: 31711309
    [No Abstract]   [Full Text] [Related]  

  • 29. [Screening of bioactive metabolites that suppress inflammation].
    Umezawa K
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1685-9. PubMed ID: 18051400
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proximal signaling molecules as potential targets for anti-inflammatory therapy.
    Löwenberg M
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):560-4. PubMed ID: 17786854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.
    Serhan CN
    J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-inflammatory substances].
    Hirasawa N; Ohuchi K
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1199-203. PubMed ID: 10771696
    [No Abstract]   [Full Text] [Related]  

  • 35. Inflammation, allergy and asthma, complex immune origin diseases: mechanisms and therapeutic agents.
    Naik SR; Wala SM
    Recent Pat Inflamm Allergy Drug Discov; 2013 Jan; 7(1):62-95. PubMed ID: 23140569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
    Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor and anti-tumor necrosis factor therapies.
    Keystone EC; Ware CF
    J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation. Signalling the fat controller.
    Serhan CN
    Nature; 1996 Nov; 384(6604):23-4. PubMed ID: 8900268
    [No Abstract]   [Full Text] [Related]  

  • 40. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.